Fig. 3From: Effect of roxadustat on iron metabolism in patients with peritoneal dialysis: a real-world 24-week studyProportion of patients with absolute iron deficiency and functional iron deficiency (A) and Hb < 100 g/L, Hb ≥ 100 g/L but < 120 g/L and Hb ≥ 120 g/L (B) by treatment (roxadustat versus ESAs) at baseline, week 8 and week 24. Hb denotes hemoglobinBack to article page